Evolent Health, Inc. <EVH.N>: Citigroup raises to buy from neutral; cuts target price to $6 from $6.75
EVH•Related News
Tenax Therapeutics Inc <TENX.O>: William Blair cuts to market perform rating
TENX•
Vestis FY26 Q3 swings to net income of $11.05 million; revenue falls 1.8% to $661.7 million vs FY25 Q3
VSTS•
SunHydrogen modules exceed 10% solar-to-hydrogen efficiency in Sparc Hydrogen testing
HYSR•
Enviri Q2 FY26 GAAP diluted loss widens to $10.70 per share; revenue falls 41% to $187 million
NVRI•
Superior Group amends, extends $200 million credit facilities with PNC-led lender group to 2031
SGC•